Point prevalence surveys of antimicrobial use among eight neonatal intensive care units in India: 2016

Background: Information about antimicrobial use is scarce and poorly understood among neonatal intensive care units (NICUs) in India. In this study, we describe antimicrobial use in eight NICUs using four point prevalence surveys (PPSs). Methods: As part of the Global Antimicrobial Resistance, Presc...

Full description

Bibliographic Details
Main Authors: Sumanth Gandra, Gerardo Alvarez-Uria, Srinivas Murki, Sanjeev K. Singh, Ravishankar Kanithi, Dasaratha R. Jinka, Ashok K. Chikkappa, Sreeram Subramanian, Anita Sharma, Dhanya Dharmapalan, Hemasree Kandraju, Anil Kumar Vasudevan, Onkaraiah Tunga, Akhila Akula, Yingfen Hsia, Mike Sharland, Ramanan Laxminarayan
Format: Article
Language:English
Published: Elsevier 2018-06-01
Series:International Journal of Infectious Diseases
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971218300766
id doaj-0a4c8fffcc3e41a1b1d318db9a8bcdd4
record_format Article
spelling doaj-0a4c8fffcc3e41a1b1d318db9a8bcdd42020-11-24T21:56:50ZengElsevierInternational Journal of Infectious Diseases1201-97121878-35112018-06-0171C202410.1016/j.ijid.2018.03.017Point prevalence surveys of antimicrobial use among eight neonatal intensive care units in India: 2016Sumanth Gandra0Gerardo Alvarez-Uria1Srinivas Murki2Sanjeev K. Singh3Ravishankar Kanithi4Dasaratha R. Jinka5Ashok K. Chikkappa6Sreeram Subramanian7Anita Sharma8Dhanya Dharmapalan9Hemasree Kandraju10Anil Kumar Vasudevan11Onkaraiah Tunga12Akhila Akula13Yingfen Hsia14Mike Sharland15Ramanan Laxminarayan16Center for Disease Dynamics, Economics & Policy, New Delhi, IndiaRural Development Trust Hospital, Bathalapalli, Andhra Pradesh, IndiaFernandez Hospital, Hyderabad, Telangana, IndiaAmrita Institute of Medical Sciences, Kochi, Kerala, IndiaSowmya Children’s Hospital, Hyderabad, Telangana, IndiaRural Development Trust Hospital, Bathalapalli, Andhra Pradesh, IndiaRural Development Trust Hospital, Kalyanadurgam, Andhra Pradesh, IndiaParamitha Children’s Hospital, Hyderabad, Telangana, IndiaFortis Hospital, Mohali, Punjab, IndiaYewale Hospital, Mumbai, Maharashtra, IndiaFernandez Hospital, Hyderabad, Telangana, IndiaAmrita Institute of Medical Sciences, Kochi, Kerala, IndiaRural Development Trust Hospital, Kalyanadurgam, Andhra Pradesh, IndiaSowmya Children’s Hospital, Hyderabad, Telangana, IndiaSt. Georges University, London, United KingdomSt. Georges University, London, United KingdomCenter for Disease Dynamics, Economics & Policy, New Delhi, IndiaBackground: Information about antimicrobial use is scarce and poorly understood among neonatal intensive care units (NICUs) in India. In this study, we describe antimicrobial use in eight NICUs using four point prevalence surveys (PPSs). Methods: As part of the Global Antimicrobial Resistance, Prescribing, and Efficacy in Neonates and Children (GARPEC) study, one-day, cross-sectional, hospital-based PPSs were conducted four times between 1 February 2016 and 28 February 2017 in eight NICUs. Using a standardized web-based electronic data entry form, detailed data were collected for babies on antimicrobials. Results: A total of 403 babies were admitted to NICUs across all survey days, and 208 (51.6%) were prescribed one or more antimicrobials. Among 208 babies, 155 (74.5%) were prescribed antimicrobials for treatment of an active infection. Among 155 babies with an active infection, treatment was empiric in 109 (70.3%). Sepsis (108, 49.1%) was the most common reason for prescribing antimicrobials. Amikacin (17%) followed by meropenem (12%) were the two most commonly prescribed antimicrobials. For community-acquired sepsis, piperacillin-tazobactam (17.5%) was the most commonly prescribed drug. A combination of ampicillin and gentamicin was prescribed in only two babies (5%). Conclusions: The recommended first-line antimicrobial agents, ampicillin and gentamicin, were rarely prescribed in Indian NICUs for community acquired neonatal sepsis.http://www.sciencedirect.com/science/article/pii/S1201971218300766Point prevalence surveyAntimicrobial useNeonatesNICUIndia
collection DOAJ
language English
format Article
sources DOAJ
author Sumanth Gandra
Gerardo Alvarez-Uria
Srinivas Murki
Sanjeev K. Singh
Ravishankar Kanithi
Dasaratha R. Jinka
Ashok K. Chikkappa
Sreeram Subramanian
Anita Sharma
Dhanya Dharmapalan
Hemasree Kandraju
Anil Kumar Vasudevan
Onkaraiah Tunga
Akhila Akula
Yingfen Hsia
Mike Sharland
Ramanan Laxminarayan
spellingShingle Sumanth Gandra
Gerardo Alvarez-Uria
Srinivas Murki
Sanjeev K. Singh
Ravishankar Kanithi
Dasaratha R. Jinka
Ashok K. Chikkappa
Sreeram Subramanian
Anita Sharma
Dhanya Dharmapalan
Hemasree Kandraju
Anil Kumar Vasudevan
Onkaraiah Tunga
Akhila Akula
Yingfen Hsia
Mike Sharland
Ramanan Laxminarayan
Point prevalence surveys of antimicrobial use among eight neonatal intensive care units in India: 2016
International Journal of Infectious Diseases
Point prevalence survey
Antimicrobial use
Neonates
NICU
India
author_facet Sumanth Gandra
Gerardo Alvarez-Uria
Srinivas Murki
Sanjeev K. Singh
Ravishankar Kanithi
Dasaratha R. Jinka
Ashok K. Chikkappa
Sreeram Subramanian
Anita Sharma
Dhanya Dharmapalan
Hemasree Kandraju
Anil Kumar Vasudevan
Onkaraiah Tunga
Akhila Akula
Yingfen Hsia
Mike Sharland
Ramanan Laxminarayan
author_sort Sumanth Gandra
title Point prevalence surveys of antimicrobial use among eight neonatal intensive care units in India: 2016
title_short Point prevalence surveys of antimicrobial use among eight neonatal intensive care units in India: 2016
title_full Point prevalence surveys of antimicrobial use among eight neonatal intensive care units in India: 2016
title_fullStr Point prevalence surveys of antimicrobial use among eight neonatal intensive care units in India: 2016
title_full_unstemmed Point prevalence surveys of antimicrobial use among eight neonatal intensive care units in India: 2016
title_sort point prevalence surveys of antimicrobial use among eight neonatal intensive care units in india: 2016
publisher Elsevier
series International Journal of Infectious Diseases
issn 1201-9712
1878-3511
publishDate 2018-06-01
description Background: Information about antimicrobial use is scarce and poorly understood among neonatal intensive care units (NICUs) in India. In this study, we describe antimicrobial use in eight NICUs using four point prevalence surveys (PPSs). Methods: As part of the Global Antimicrobial Resistance, Prescribing, and Efficacy in Neonates and Children (GARPEC) study, one-day, cross-sectional, hospital-based PPSs were conducted four times between 1 February 2016 and 28 February 2017 in eight NICUs. Using a standardized web-based electronic data entry form, detailed data were collected for babies on antimicrobials. Results: A total of 403 babies were admitted to NICUs across all survey days, and 208 (51.6%) were prescribed one or more antimicrobials. Among 208 babies, 155 (74.5%) were prescribed antimicrobials for treatment of an active infection. Among 155 babies with an active infection, treatment was empiric in 109 (70.3%). Sepsis (108, 49.1%) was the most common reason for prescribing antimicrobials. Amikacin (17%) followed by meropenem (12%) were the two most commonly prescribed antimicrobials. For community-acquired sepsis, piperacillin-tazobactam (17.5%) was the most commonly prescribed drug. A combination of ampicillin and gentamicin was prescribed in only two babies (5%). Conclusions: The recommended first-line antimicrobial agents, ampicillin and gentamicin, were rarely prescribed in Indian NICUs for community acquired neonatal sepsis.
topic Point prevalence survey
Antimicrobial use
Neonates
NICU
India
url http://www.sciencedirect.com/science/article/pii/S1201971218300766
work_keys_str_mv AT sumanthgandra pointprevalencesurveysofantimicrobialuseamongeightneonatalintensivecareunitsinindia2016
AT gerardoalvarezuria pointprevalencesurveysofantimicrobialuseamongeightneonatalintensivecareunitsinindia2016
AT srinivasmurki pointprevalencesurveysofantimicrobialuseamongeightneonatalintensivecareunitsinindia2016
AT sanjeevksingh pointprevalencesurveysofantimicrobialuseamongeightneonatalintensivecareunitsinindia2016
AT ravishankarkanithi pointprevalencesurveysofantimicrobialuseamongeightneonatalintensivecareunitsinindia2016
AT dasaratharjinka pointprevalencesurveysofantimicrobialuseamongeightneonatalintensivecareunitsinindia2016
AT ashokkchikkappa pointprevalencesurveysofantimicrobialuseamongeightneonatalintensivecareunitsinindia2016
AT sreeramsubramanian pointprevalencesurveysofantimicrobialuseamongeightneonatalintensivecareunitsinindia2016
AT anitasharma pointprevalencesurveysofantimicrobialuseamongeightneonatalintensivecareunitsinindia2016
AT dhanyadharmapalan pointprevalencesurveysofantimicrobialuseamongeightneonatalintensivecareunitsinindia2016
AT hemasreekandraju pointprevalencesurveysofantimicrobialuseamongeightneonatalintensivecareunitsinindia2016
AT anilkumarvasudevan pointprevalencesurveysofantimicrobialuseamongeightneonatalintensivecareunitsinindia2016
AT onkaraiahtunga pointprevalencesurveysofantimicrobialuseamongeightneonatalintensivecareunitsinindia2016
AT akhilaakula pointprevalencesurveysofantimicrobialuseamongeightneonatalintensivecareunitsinindia2016
AT yingfenhsia pointprevalencesurveysofantimicrobialuseamongeightneonatalintensivecareunitsinindia2016
AT mikesharland pointprevalencesurveysofantimicrobialuseamongeightneonatalintensivecareunitsinindia2016
AT ramananlaxminarayan pointprevalencesurveysofantimicrobialuseamongeightneonatalintensivecareunitsinindia2016
_version_ 1725856864294404096